Key facts
- WINT - WINDTREE THERAPEUTICS INC /DE/ has 18 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
Insider Transactions Reported by 18 Insiders of WINDTREE THERAPEUTICS INC /DE/
- Symbol
- WINT on OTC
- Location
- Warrington, PA
Change
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
WINDTREE THERAPEUTICS INC /DE/ executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| James Huang | Director | $3,819,976 | Mixed | 22 Feb 2023 | ||
| Center Laboratories, Inc. | 10%+ Owner | $2,527,492 | Mixed | 20 May 2020 | ||
| John P. Hamill | Svp & Cfo | $74,249 | Mixed | 26 Jul 2022 | ||
| Craig Fraser | President and CEO, Director | $59,032 | Mixed | 08 Oct 2024 | ||
| Steven Simonson | SVP, Chief Medical Officer | $17,793 | Mixed | 22 Jul 2024 | ||
| Eric Curtis | Svp & Coo | $16,237 | Mixed | 23 Aug 2023 | ||
| Jamie McAndrew | VP, Controller, & CAO | $10,438 | Mixed | 24 Aug 2023 | ||
| Mark Strobeck | Director | $2,346 | Mixed | 23 Aug 2023 | ||
| Daniel E. Geffken | Director | $2,218 | Mixed | 23 Aug 2023 | ||
| Robert A. Scott | Director | $2,175 | Mixed | 23 Aug 2023 | ||
| Leslie J. Williams | Director | $2,175 | Mixed | 23 Aug 2023 | ||
| Diane Carman Esq. | SVP & General Counsel | $1,251 | Mixed | 28 Feb 2023 | ||
| Andrew Albert Kucharchuk | Director | Mixed | 03 Aug 2025 | |||
| Jed Latkin | Director | Mixed | 13 Aug 2024 | |||
| Saundra L. Pelletier | Director | Mixed | 13 Aug 2024 | |||
| Leanne Kelly | Director | Mixed | 08 Jan 2025 | |||
| John A. Tattory | Interim CFO | Mixed | 27 Jan 2023 | |||
| Bioengine Capital Inc. | 10%+ Owner | Mixed | 20 May 2020 |
Top shareholders of WINDTREE THERAPEUTICS INC /DE/ (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
2.6%
|
288,552
|
$28,855 | $0 | 31 Dec 2024 | |
| Center Laboratories, Inc. |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
2,782,352
mixed-class rows
|
$2,527,492 | — | 20 May 2020 | |
| Bioengine Capital Inc. |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
304,176
mixed-class rows
|
— | — | 20 May 2020 | |
| James Huang |
3/4/5
|
Director |
—
mixed-class rows
|
5,970,058
mixed-class rows
|
$3,819,976 | — | 22 Feb 2023 | |
| John P. Hamill |
3/4/5
|
SVP & CFO |
—
class O/S missing
|
72,800
|
$74,249 | — | 26 Jul 2022 | |
| Craig Fraser |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
12,669
mixed-class rows
|
$59,032 | — | 08 Oct 2024 | |
| Steven Simonson |
3/4/5
|
SVP, Chief Medical Officer |
—
mixed-class rows
|
43,933
mixed-class rows
|
$17,793 | — | 22 Jul 2024 | |
| Eric Curtis |
3/4/5
|
SVP & COO |
—
mixed-class rows
|
37,920
mixed-class rows
|
$16,237 | — | 23 Aug 2023 | |
| Jamie McAndrew |
3/4/5
|
VP, Controller, & CAO |
—
class O/S missing
|
10,234
|
$10,438 | — | 24 Aug 2023 | |
| Mark Strobeck |
3/4/5
|
Director |
—
mixed-class rows
|
5,750
mixed-class rows
|
$2,346 | — | 23 Aug 2023 | |
| Daniel E. Geffken |
3/4/5
|
Director |
—
mixed-class rows
|
5,225
mixed-class rows
|
$2,218 | — | 23 Aug 2023 | |
| Leslie J. Williams |
3/4/5
|
Director |
—
mixed-class rows
|
5,183
mixed-class rows
|
$2,175 | — | 23 Aug 2023 | |
| Robert A. Scott |
3/4/5
|
Director |
—
mixed-class rows
|
5,183
mixed-class rows
|
$2,175 | — | 23 Aug 2023 | |
| Diane Carman Esq. |
3/4/5
|
SVP & General Counsel |
—
class O/S missing
|
1,227
|
$1,251 | — | 28 Feb 2023 |
Recent Insider Transactions by Companies or Individuals for WINDTREE THERAPEUTICS INC /DE/
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.